A Scharfman

471 total citations
26 papers, 402 citations indexed

About

A Scharfman is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, A Scharfman has authored 26 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Genetics. Recurrent topics in A Scharfman's work include Glycosylation and Glycoproteins Research (6 papers), Cystic Fibrosis Research Advances (5 papers) and Occupational and environmental lung diseases (4 papers). A Scharfman is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Cystic Fibrosis Research Advances (5 papers) and Occupational and environmental lung diseases (4 papers). A Scharfman collaborates with scholars based in France, China and Mali. A Scharfman's co-authors include G Lamblin, Pascal Roussel, Nicole Houdret, P Roussel, Reuben Ramphal, Christophe Carnoy, Jean‐Marie Beau, Joël Mazurier, Patrick O. Humbert and Philippe Roussel and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Infection and Immunity and European Respiratory Journal.

In The Last Decade

A Scharfman

25 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Scharfman France 12 202 154 49 44 42 26 402
Andrée Scharfman France 7 315 1.6× 183 1.2× 135 2.8× 62 1.4× 67 1.6× 10 542
O Bajolet-Laudinat France 8 281 1.4× 190 1.2× 14 0.3× 57 1.3× 27 0.6× 8 502
Valerie Sloane United States 6 222 1.1× 76 0.5× 17 0.3× 192 4.4× 42 1.0× 6 493
Michael J. Ansfield United States 12 167 0.8× 197 1.3× 11 0.2× 155 3.5× 13 0.3× 15 528
K. Chul Kim United States 9 176 0.9× 79 0.5× 24 0.5× 100 2.3× 37 0.9× 9 324
Akiyuki Yamamoto Japan 14 203 1.0× 86 0.6× 10 0.2× 20 0.5× 30 0.7× 38 734
G Spik France 14 299 1.5× 113 0.7× 67 1.4× 111 2.5× 19 0.5× 22 715
Alba Miranda-Ribera United States 9 174 0.9× 40 0.3× 20 0.4× 103 2.3× 27 0.6× 17 360
Shankar Iyer United States 10 167 0.8× 22 0.1× 32 0.7× 123 2.8× 44 1.0× 15 409
G.A. Baumbach United States 13 191 0.9× 23 0.1× 9 0.2× 80 1.8× 23 0.5× 19 498

Countries citing papers authored by A Scharfman

Since Specialization
Citations

This map shows the geographic impact of A Scharfman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Scharfman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Scharfman more than expected).

Fields of papers citing papers by A Scharfman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Scharfman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Scharfman. The network helps show where A Scharfman may publish in the future.

Co-authorship network of co-authors of A Scharfman

This figure shows the co-authorship network connecting the top 25 collaborators of A Scharfman. A scholar is included among the top collaborators of A Scharfman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Scharfman. A Scharfman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Scharfman, A, et al.. (1996). Interactions Between Glycoconjugates From Human Respiratory Airways and Pseudomonas aeruginosa. American Journal of Respiratory and Critical Care Medicine. 154(4_Part_2). S163–S169. 35 indexed citations
3.
Scharfman, A, G Lamblin, & Pascal Roussel. (1995). Interactions between human respiratory mucins and pathogens. Biochemical Society Transactions. 23(4). 836–839. 20 indexed citations
4.
Wu, Jiang, et al.. (1992). Selective inhibition of normal murine myelopoiesis "in vitro" by a Hox 2.3 antisense oligodeoxynucleotide.. PubMed. 38(4). 367–76. 16 indexed citations
5.
Wu, Jiong, et al.. (1991). Recombinant human granulocyte macrophage colony-stimulating factor (rhGM-CSF) induces human macrophage production of transforming growth factor-alpha.. PubMed. 37(4). 413–9. 6 indexed citations
6.
Scharfman, A, Reuben Ramphal, Christel Neut, et al.. (1991). Arylneuraminidase activity of Pseudomonas aeruginosa does not degrade natural substrates such as human respiratory mucins. Infection and Immunity. 59(11). 4283–4285. 4 indexed citations
7.
Scharfman, A, et al.. (1991). An attempt to evaluate lung aggression in monkey silicosis: hydrolases, peroxidase and antiproteases activities in serial bronchoalveolar lavages. European Respiratory Journal. 4(2). 191–204. 20 indexed citations
8.
Scharfman, A, et al.. (1989). Special neutrophil elastase inhibitory activity in BAL fluid from patients with silicosis and asbestosis. European Respiratory Journal. 2(8). 751–757. 8 indexed citations
9.
Houdret, Nicole, Jamila Alessandra Perini, C. Galabert, et al.. (1986). The high lipid content of respiratory mucins in cystic fibrosis is related to infection. Biochimica et Biophysica Acta (BBA) - General Subjects. 880(1). 54–61. 44 indexed citations
10.
Scharfman, A, et al.. (1982). Changes in glycosidase activities and surface lectin receptors of guinea-pig alveolar macrophages activated by Corynebacterium parvum.. PubMed. 28(1). 111–8. 1 indexed citations
11.
Scharfman, A, et al.. (1981). PROTEASES AND ANTIPROTEASES IN BRONCHOALVEOLAR LAVAGE. Elsevier eBooks. 16 Suppl. 247–260. 10 indexed citations
12.
Scharfman, A, et al.. (1981). Comparison of three methods for protein measurement: application to bronchoalveolar lavage fluids.. PubMed. 16(6). 785–9. 1 indexed citations
13.
Scharfman, A, et al.. (1979). [Proteins and enzymes in normal human bronchial washing fluids (author's transl)].. PubMed. 15(4). 611–24. 3 indexed citations
14.
Scharfman, A, J.J. Lafitte, A B Tonnel, et al.. (1979). Glycosidases and proteases of alveolar macrophages obtained by bronchoalveolar lavage from smokers and non-smokers. Lung. 157(1). 135–142. 8 indexed citations
15.
Scharfman, A, et al.. (1979). [Effect of Corynebacterium parvum on the glycosidases in guinea pig alveolar macrophages. Role of the way of introduction (author's transl)].. PubMed. 14(5). 485–92. 1 indexed citations
16.
Scharfman, A, Pascal Roussel, G Biserte, et al.. (1976). Etude des activites de peptidases des leucocytes humains et des macrophages alveolaires de l'homme et du cobaye. Clinica Chimica Acta. 66(3). 371–378. 2 indexed citations
18.
Scharfman, A, et al.. (1973). [Serum alpha macroglobulins of the rabbit].. PubMed. 18(6). 507–13. 2 indexed citations
19.
Boulanger, Pierre, Nicole Houdret, A Scharfman, & Pierre Lemay. (1972). The Role of Surface Sialic Acid in Adenovirus-cell Adsorption. Journal of General Virology. 16(3). 429–434. 12 indexed citations
20.
Scharfman, A, et al.. (1970). [The alpha-macroglobulins of rabbit seru].. PubMed. 271(25). 2412–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026